Levofloxacin Injection
Product Images NDC 63323-355

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 63323-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bag (Bag)

Bag (Bag)
Levofloxacin s e in 5% Dextrose Injection is a prescription medication used for intravenous infusion. Each 50 mL container contains a 250 mg dilute solution of levofloxacin (5 mg/mL) in 5% dextrose. The product may contain hydrochloric acid and/or sodium hydroxide for pH adjustment, with a pH range of 3.8 to 5.8. The infusion should be administered in 60 minutes, and additives should not be added or infused through the same intravenous line. The product is for single use and should be used immediately upon removal from the overwrap. Unused portions should be discarded. The medication guide must be dispensed to the patient. The product should only be used if the solution is clear and the container is undamaged. The usual adult dosage should be found in the insert. This product does not contain natural rubber latex or polyvinyl chloride (PVC) and must not be used in series connection. The manufacturer is Fresenius Kabi USA, LLC, and the product is made in Norway.*
FDA Label Image

Chemicalstructure

Chemicalstructure
FDA Label Image

Fk Only

Fk Only
FDA Label Image

Figure 2 (Levofloxacin F2)

Figure 2 (Levofloxacin F2)
This text provides a graph titled "Mean Levofloxacin Plasma Concentration" and a dosage profile of 750mg for both oral tablets and intravenous infusion. The graph likely shows how the plasma concentration of Levofloxacin changes over time after taking the medication.*
FDA Label Image

Figure 3 (Levofloxacin F3)

Figure 3 (Levofloxacin F3)
The text appears to be a part of a scientific figure and provides information about levofloxacin plasma concentration. It indicates that the figure shows the mean plasma concentration of levofloxacin over time for a dose of 500 mg. The text also mentions the route of administration as a tablet that is taken orally and an intravenous (IV) dose of 500 mg.*
FDA Label Image

Overwrap (Overwrap)

Overwrap (Overwrap)
This is a medication description for Levofloxacin R+ 250 mg in 5% Dextrose Injection, which is administered through intravenous infusion. The medication is stored at 20 to 25°C and is for single use only. The overwrap must not be removed until ready to use, and the medication should be used promptly after the pouch is opened. It is important to discard any unused portion, and the medication should not be used with additives or infused through the same intravenous line. The text also includes instructions for how to tear the overwrap and notable storage information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.